• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Proc Natl Acad Sci U S A . Extra gene coding capacity of SARS-CoV-2 provides a virus engineering platform for in vitro and in vivo applications

tetano

Editor, Senior Moderator
Proc Natl Acad Sci U S A


. 2026 Jun 30;123(26):e2532920123.
doi: 10.1073/pnas.2532920123. Epub 2026 Jun 24.
Extra gene coding capacity of SARS-CoV-2 provides a virus engineering platform for in vitro and in vivo applications

Taksoo Kim[SUP] 1 [/SUP], Asim Biswas[SUP] 1 [/SUP], Sangam Kandel[SUP] 1 [/SUP], Makoto Kuroda[SUP] 1 [/SUP], Peter J Halfmann[SUP] 1 [/SUP], Yoshihiro Kawaoka[SUP] 1 2 3 4 [/SUP]


Affiliations
Abstract

The genomic flexibility of orthocoronaviruses, including severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is showcased by the presence of accessory genes, which vary in number among virus species and strains. Given this flexibility, the viral coding capacity can be artificially expanded to express a heterologous gene from the viral genome, thereby enabling the development of a viral vector platform. Here, we systematically explored the extra gene coding capacity of SARS-CoV-2 by inserting an extra reporter gene at every intergenic region in its genome. We revealed the entire scheme of its extra gene expression and identified a genomic location that stably expresses reporter genes while maintaining the wild-type viral phenotype. Using this construct, we developed a set of fluorescent and luminescent reporter SARS-CoV-2 viruses available for in vivo flow cytometry and in vitro antiviral screening. Flow cytometric analysis with these reporter viruses revealed cell type-specific dynamics of SARS-CoV-2 infection in the lung tissue of K18-hACE2 mice. Our findings offer a platform for SARS-CoV-2 genome engineering, providing a set of reporter viruses for research applications.

Keywords: SARS-CoV-2; coronavirus; in vivo flow cytometry; reporter virus; viral vector.

 
Back
Top